in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Orchid exits API jv in China
10:47 AM MST | November 12, 2012 | Deepti Ramesh
Orchid Chemicals & Pharmaceuticals (Chennai, India), a leading Indian pharmaceutical company, says it is exiting its 50-50 active pharmaceutical ingredient (API) manufacturing joint venture in China with North China Pharmaceutical Corp. (NCPC; Shijiazhuang, China), NCPC-Orchid Pharmaceuticals (Shijiazhuang). Orchid’s 50% stake in the jv will be transferred to NCPC for a total cash consideration of $13.9 million, Orchid says. Orchid and NCPC formed the jv in 2002 to establish a cephalosporin API manufacturing facility at Shijiazhuang. “With...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee